A 19-year-old man with a known history of sickle cell disease (HbSS) is brought to the emergency department with a 6-hour history of excruciating pain in his lower back, thighs, and chest. He states that the pain is 10 out of 10 in intensity and began shortly after he went for a long run in cold weather. He denies fever, cough, or shortness of breath. His temperature is 37.2°C (98.8°F), blood pressure is 138/86 mmHg, heart rate is 112/min, and oxygen saturation is 96% on room air. On physical examination, he is in visible distress, shifting positions frequently to find comfort. There is no chest wall tenderness or focal neurological deficit. Laboratory studies show a hemoglobin of 8.2 g/dL (baseline 8.0 g/dL) and a reticulocyte count of 12%.
Which of the following is the most appropriate next step in the management of this patient?
The correct answer is:
C) Incentive spirometry and intravenous morphine
This patient is experiencing an acute sickle cell vaso-occlusive crisis, also known as a pain crisis. The pathophysiology involves the polymerization of deoxygenated hemoglobin S, which causes red blood cells to take on a sickle shape. These rigid cells obstruct the microvasculature, leading to tissue ischemia and severe pain. The hallmarks of management are rapid and adequate analgesia, often requiring opioids like morphine, and supportive care. Incentive spirometry is a critical component of management for any patient hospitalized with a vaso-occlusive crisis, especially those with chest or back pain. It helps prevent atelectasis and progression to acute chest syndrome, a leading cause of mortality in sickle cell patients.
Answer choice A: Aggressive intravenous fluid resuscitation at twice the maintenance rate, is incorrect. While maintaining hydration is important, aggressive over-hydration (e.g., boluses or high-rate infusions) should be avoided unless the patient is clinically dehydrated. Excessive fluids can lead to volume overload, pulmonary edema, and an increased risk of acute chest syndrome.
Answer choice B: Emergent exchange transfusion, is incorrect. Exchange transfusion is reserved for life-threatening complications of sickle cell disease, such as stroke, severe acute chest syndrome, or multi-organ failure. It is not indicated for an uncomplicated vaso-occlusive crisis.
Answer choice D: Oral hydroxyurea and folic acid supplementation, is incorrect. Hydroxyurea is a maintenance medication for sickle cell disease that increases the production of fetal hemoglobin (HbF) to prevent future crises. It is not used to treat an acute episode. Folic acid is also a typical part of maintenance therapy used to support the high erythropoietic demands of hemolytic anemia but has no role in acute pain management.
Answer choice E: Prophylactic broad-spectrum antibiotics, is incorrect. While patients with sickle cell disease are functionally asplenic and at high risk for encapsulated bacterial infections, antibiotics are only indicated if the patient is febrile or there is a high clinical suspicion of infection. This patient is currently afebrile.
Key Learning Point
The management of an acute sickle cell vaso-occlusive crisis focuses on prompt pain control and the prevention of complications. Analgesia should be instituted within 30-60 minutes of arrival. Incentive spirometry is important for patients hospitalized with vaso-occlusive crisis to reduce the incidence of acute chest syndrome.
